USPTO serial 79294724
T ACELLT APEIRON CELL THERAPIES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 26, 2022
- Examiner
- EISNACH, MICHAEL PATRICK
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with T ACELLT APEIRON CELL THERAPIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological preparations for industrial and scientific purposes | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for treating and preventing cancer, pharmaceutical preparations for cellular therapy; diagnostic preparations for medical purposes; sanitary preparations for medical purposes | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, in particular analysis services in the field of research, development and diagnostics, namely, scientific research, medical research for medical applications, development of new products for others; industrial analysis and research services in the field of cancer treatment, cell processing, and cellular therapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by APEIRON Biologics GmbH
- Other trademarks owned by APEIRON BIOLOGICS AG
- Other trademarks owned by APEIRON BIOLOGICS AG
- Other trademarks owned by APEIRON BIOLOGICS AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named T ACELLT APEIRON CELL THERAPIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 11, 2026 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| May 9, 2025 | RHRD | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | — |
| Jan 16, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 4, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 20, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 28, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 27, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 26, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 26, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 26, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 20, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 20, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 20, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 20, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 15, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 10, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 10, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 20, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 20, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 20, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 4, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 4, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 4, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 4, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 4, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 21, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 2, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 2, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 26, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 23, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 23, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 23, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 20, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 19, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 19, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 9, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 9, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 1, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 30, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 9, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 5, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 1, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |